SCHEMBL4257325

SCHEMBL4257325

CCP(CC)c1ccccc1.[Ru]

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
TP53 P04637 1/20 0.39
ESR1 P03372 4/20 0.36
ESR2 Q92731 4/20 0.36
KCNN4 O15554 1/20 0.36
PSIP1 O75475 1/20 0.33
KDM4E B2RXH2 1/20 0.32
ALDH1A1 P00352 1/20 0.32
GAA P10253 1/20 0.32
HPGD P15428 1/20 0.32
MAPT P10636 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
LMNA P02545 2/20 0.32
TSHR P16473 1/20 0.32
ALOX12 P18054 1/20 0.32
ACHE P22303 1/20 0.32
SLC9A1 P19634 1/20 0.31
MEN1 O00255 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL231466 0.97 CYP3A4 (0.45) CYP3A4TDP1TP53ESR1ESR2
SCHEMBL5588513 0.94 CYP3A4 (0.43) CYP3A4TDP1TP53ESR1ESR2
SCHEMBL11530312 0.94 CYP3A4 (0.43) CYP3A4TDP1TP53ESR1ESR2
Phosphine SCHEMBL28045431 0.94 CYP3A4 (0.43) CYP3A4TDP1TP53ESR1ESR2
SCHEMBL29598351 0.94 CYP3A4 (0.43) CYP3A4TDP1TP53ESR1ESR2
SCHEMBL11551492 0.94 CYP3A4 (0.43) CYP3A4TDP1TP53ESR1ESR2
Hydrochloric Acid SCHEMBL11528405 0.92 TDP1 (0.41) CYP3A4TDP1TP53ESR1ESR2
SCHEMBL11208466 0.90 CYP3A4 (0.39) CYP3A4TDP1TP53ESR1ESR2
SCHEMBL7763562 0.90 CYP3A4 (0.39) CYP3A4TDP1TP53ESR1ESR2
SCHEMBL1984766 0.87 CYP3A4 (0.38) CYP3A4TDP1TP53ESR1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026090602-A1 PIGMENTED RESIN AND CATALYST COMPOSITIONS MATERIA, INC. (US) 2026-04-30 WO disclosed
WO-2025245037-A1 CYCLIC OLEFIN COMPOSITIONS, ROMP COMPOSITIONS THEREOF, AND APPLICATIONS THEREOF MATERIA, INC. (US) 2025-11-27 WO disclosed
CN-113423549-B Coating composition 马特里亚公司 2024-06-25 CN disclosed
CN-116120715-A Cycloolefin resin composition containing functional elastomer 马特里亚公司 2023-05-16 CN disclosed
CN-109982995-B Preparation of amino acids and amino acid derivatives 优美科股份公司及两合公司 2022-09-30 CN disclosed
EP-3894163-A1 COATING COMPOSITIONS Materia, Inc. (US) 2021-10-20 EP disclosed
CN-107250202-B ROMP polymers with improved resistance to hydrocarbon fluids 马特里亚公司 2021-10-01 CN disclosed
CN-113423549-A Coating composition 马特里亚公司 2021-09-21 CN disclosed
WO-2020123946-A1 COATING COMPOSITIONS MATERIA, INC. (US) 2020-06-18 WO disclosed
CN-109982995-A PREPARATION OF AMINO ACIDS AND AMINO ACID DERIVATIVES 优美科股份公司及两合公司 2019-07-05 CN disclosed
CN-101490126-A Ring-opening metathesis polymer, hydrogenated product thereof, process for producing the same, and use thereof MITSUI CHEMICALS INC (JP) 2009-07-22 CN disclosed
US-20090124772-A1 PROCESS FOR PRODUCING ORGANIC TRANSITION METAL COMPLEX COMPOUND, METATHESIS CATALYST PRODUCED BY USING THE SAME, RING-OPENING METATHESIS POLYMER OBTAINABLE WITH THE METATHESIS CATALYST, AND PROCESS FOR PRODUCING THE POLYMER MITSUI CHEMICALS, INC. (JP) 2009-05-14 US disclosed
CN-101291944-A Process for producing organic transition metal complex compound, metathesis catalyst produced by the process, metathesis polymer formed by ring opening polymerization with the same, and process for pr MITSUI CHEMICALS INC (JP) 2008-10-22 CN disclosed
EP-1950216-A1 PROCESS FOR PRODUCING ORGANIC TRANSITION METAL COMPLEX COMPOUND, METATHESIS CATALYST PRODUCED BY THE PROCESS, METATHESIS POLYMER FORMED BY RING OPENING POLYMERIZATION WITH THE SAME, AND PROCESS FOR PRODUCING POLYMER WITH THE SAME Mitsui Chemicals, Inc. (JP) 2008-07-30 EP disclosed
EP-1160245-B1 PROCESS FOR PRODUCING CARBONYL COMPOUNDS BY DEHYDROGENATION OF ALCOHOLS MITSUBISHI CHEM CORP (JP) 2007-11-14 EP disclosed
CN-1233685-C Fluorinated cycloolefin polymer, cycloolefin monomer thereof, preparation method of polymer and application of polymer MITSUI CHEMICALS INC (JP) 2005-12-28 CN disclosed
CN-1462286-A Fluorinated cycloolefin polymers, its cycloolefin monomers processes for preparation of polymers thereof and use of the same MITSUI CHEMICALS INC (JP) 2003-12-17 CN disclosed
US-6492532-B2 Method for producing carbonyl compound by dehydrogenating alcohol MITSUBISHI CHEMICAL CORPORATION (JP) 2002-12-10 US disclosed
US-20020002289-A1 Method for producing carbonyl compound by dehydrogenating alcohol MITSUBISHI CHEMICAL CORPORATION (JP) 2002-01-03 US disclosed
EP-1160245-A1 PROCESS FOR PRODUCING CARBONYL COMPOUNDS BY DEHYDROGENATION OF ALCOHOLS MITSUBISHI CHEMICAL CORPORATION (JP) 2001-12-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090124772-A1 PROCESS FOR PRODUCING ORGANIC TRANSITION METAL COMPLEX COMPOUND, METATHESIS CATALYST PRODUCED BY USING THE SAME, RING-OPENING METATHESIS POLYMER OBTAINABLE WITH THE METATHESIS CATALYST, AND PROCESS FOR PRODUCING THE POLYMER PORCN, ICMT, ME1 CYP3A4 672/4885TDP1 4360/4885TP53 4294/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.